DrugPatentWatch Database Preview
Profile for Canada Patent: 2727830
US Patent Family Members and Approved Drugs for Canada Patent: 2727830
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Oct 19, 2024 | Celgene | POMALYST | pomalidomide |
➤ Try a Free Trial | Jun 17, 2025 | Celgene | POMALYST | pomalidomide |
➤ Try a Free Trial | May 15, 2023 | Celgene | REVLIMID | lenalidomide |
➤ Try a Free Trial | Oct 7, 2023 | Celgene | REVLIMID | lenalidomide |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |